Regulations.gov document
Notifying the Food and Drug Administration of a Permanent Discontinuance or Interruption…
Notice · FDA-2022-D-0053 · posted Feb 7, 2022
Key facts
| Document ID | FDA-2022-D-0053-0004 |
|---|---|
| Title | Notifying the Food and Drug Administration of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry and Food and Drug Administration Staff; Availability; Extension of Comment Period |
| Document type | Notice |
| Subtype | Extension of Comment Period |
| Agency | FDA |
| Docket | FDA-2022-D-0053 |
| Posted | Feb 7, 2022 |
| Federal Register citation | 87 FR 6875 |
| FR document number | 2022-02472 |
| Comment period opens | Feb 7, 2022 |
| Comments due | Apr 12, 2022 |
| Effective date | Feb 7, 2022 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: